Updates:

December 2022:

• Guidelines updated: EAU 2022, NCCN v2.2022 on bladder cancer and ESMO 2022, ASCO 2021, NCCN v1.2022 on toxicities related to immunotherapy
• Minor textual changes

April 2021:

• Guidelines added: NCCN v1.2021 on management of immunotherapy-related toxicities, ESMO on bladder cancer
• Guidelines updated: EAU 2021, NCCN v2.2021 on bladder cancer
• Evidence updated

July 2020:

• Topic created